110 related articles for article (PubMed ID: 6968281)
1. [Plasmapheresis therapy in severe lupus erythematosus D.N.A. serum antodies and erythrocyte sedimentation rate for therapy control (author's transl)].
Meffert H; Böhm F; Apostoloff E; Kramm HJ
Dermatol Monatsschr; 1980 May; 166(5):331-5. PubMed ID: 6968281
[No Abstract] [Full Text] [Related]
2. Plasmapheresis in the treatment of systemic lupus erythematosus.
Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
[TBL] [Abstract][Full Text] [Related]
3. Cryopheresis in the treatment of systemic lupus erythematosus.
Stewart DW; Ballard JO; Schoolwerth AC
Trans Am Soc Artif Intern Organs; 1984; 30():222-6. PubMed ID: 6335931
[No Abstract] [Full Text] [Related]
4. [Anti-DNA antibodies in systemic lupus erythematosus (author's transl)].
Clotet B; Ruibal A; Pigrau C; Murcia C; Pahissa A; Lience E
Med Clin (Barc); 1982 Feb; 78(4):128-131. PubMed ID: 6978438
[No Abstract] [Full Text] [Related]
5. [Studies on systemic lupus erythematosus. (I) On experimental production of antinuclear factors by drugs and DNA-administration and renal immunohistology (author's transl)].
Kawada K
Nihon Jinzo Gakkai Shi; 1977 Jun; 19(6):391-400. PubMed ID: 303716
[No Abstract] [Full Text] [Related]
6. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
[No Abstract] [Full Text] [Related]
7. Extracorporeal removal of anti-DNA antibodies in systemic lupus erythematosus using DNA-collagen films.
Laville M; el Habib R; Traeger J; Coulet PR; Gautheron DC; Sanhadji K; My H; Zech PY
Life Support Syst; 1983; 1 Suppl 1():65-70. PubMed ID: 6400735
[No Abstract] [Full Text] [Related]
8. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
Voss A; Nielsen EH; Svehag SE; Junker P
J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
[TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis: an adjunct therapy in severe progressive neuropsychiatric lupus.
Gokhale YA; Bhide S; Rajadhyaksha S; Bichile LS; Hase NK
J Assoc Physicians India; 2001 Oct; 49():986-9. PubMed ID: 11848331
[TBL] [Abstract][Full Text] [Related]
10. [Indications for the application of plasmapheresis (author's transl)].
Samtleben W; Blumenstein M; Habersetzer R; Gurland HJ
MMW Munch Med Wochenschr; 1982 Jul; 124(27):641-5. PubMed ID: 6810157
[No Abstract] [Full Text] [Related]
11. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA.
Jones JV; Robinson MF; Parciany RK; Layfer LF; McLeod B
Arthritis Rheum; 1981 Sep; 24(9):1113-20. PubMed ID: 6975635
[TBL] [Abstract][Full Text] [Related]
13. [Therapy with corticoid pulses, plasmapheresis, and corticoid pulses combined with plasmapheresis in systemic lupus erythematosus].
Carreira PE; Gómez-Reino JJ; Morillas L; Mateo I; Ibero I; Millet VG; Páramo MJ
Med Clin (Barc); 1986 Jun; 87(5):179-82. PubMed ID: 3736247
[No Abstract] [Full Text] [Related]
14. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
15. [Study of blood lymphocytes in systemic lupus erythematosus].
Delbarre F; Pompidou A; Kahan A; Brouilhet H; Le Gô A; Amor B
Pathol Biol (Paris); 1971 Apr; 19(7):379-87. PubMed ID: 4931701
[No Abstract] [Full Text] [Related]
16. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.
Arthritis Rheum; 1999 Sep; 42(9):1785-96. PubMed ID: 10513791
[TBL] [Abstract][Full Text] [Related]
17. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
[TBL] [Abstract][Full Text] [Related]
18. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
Tilz GP; Teubl I; Kopplhuber C; Vollmann H; Lanzer G
Med Klin; 1976 Nov; 71(45):1952-7. PubMed ID: 825711
[TBL] [Abstract][Full Text] [Related]
20. [The erythrocyte sedimentation rate in patients with systemic lupus erythematosus].
Shulaeva EV
Vrach Delo; 1972 Dec; 12():51-3. PubMed ID: 4659218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
